Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹61 Cr₹58 Cr₹43 Cr₹38 Cr₹16 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹61 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹61 Cr
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr
Mar2021₹16 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹61 Cr
4.82
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr
140.58
Mar2021 ₹16 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,689.6 Cr 3.5% 9.6% -21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

3.5%

9.6%

-21.4%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses